Put Buying in AstraZeneca (AZN) Suggests Near-Term Bearish Bias in Shares -Susquehanna

Susquehanna options strategist Alison Edwards notes near-term bearish bias in AstraZeneca (NYSE: AZN), as investors purchased about 3000 Aug 28.5 Puts and 6,000 Aug 30 Puts.

You May Also Be Interested In

• Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
• Trump on Iran: we're trying to work out a deal that's fair
• Varonis Systems (VRNS) call put ratio 4.4 calls to 1 put with a focus on July 35, 40 and 45 calls as share price up 6.4%